Animal Models of Visceral Leishmaniasis
Authors:
- S.L. CroftSCS.L. Croft
- V. YardleyVYV. Yardley
- 1 January 1999
- book chapter
- Published by Elsevier
- p. 783-787
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Leishmania and human immunodeficiency virus coinfection: the first 10 yearsClinical Microbiology Reviews, 1997
- Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 YearsClinical Infectious Diseases, 1997
- Strategies for immune intervention in visceral leishmaniasisPathogens and Global Health, 1995
- Vaccines against leishmaniasisPathogens and Global Health, 1995
- Leishmaniases of the New World: current concepts and implications for future researchClinical Microbiology Reviews, 1993
- Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidineAntimicrobial Agents and Chemotherapy, 1993
- Practical progress and new drugs for changing patterns of leishmaniasisParasitology Today, 1993
- Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.Journal of Clinical Investigation, 1989
- Chemotherapy of visceral leishmaniasis (Leishmania donovani) in the squirrel monkey (Saimiri sciureus)Pathogens and Global Health, 1985
- Testing of drugs for antileishmanial activity in golden hamsters infected with Leishmania donovaniInternational Journal for Parasitology, 1977